Oligosol Manganese Cobalt 28 Ampoules

Oligosol Manganese Cobalt - 28 Ampoules

Spasms, Involuntary Contractions – For Adults and Adolescents

✔️ For Whom: Adults, Adolescents
✔️ Pregnant Women: Not recommended
✔️ Breastfeeding: Not recommended
✔️ Form: Ampoules (2 ml each)

🌿 Purpose:
Oligosol Manganese Cobalt ampoules are primarily intended for adults and adolescents over 15 years old as a terrain modifier. They are particularly beneficial during states of neurovegetative dystonia, a condition often linked to involuntary spasms or muscle contractions.

This product is used in oligotherapy, a therapeutic approach that involves trace elements to support overall well-being.

💧 Active Ingredients (per 2 ml ampoule):

• Manganese Gluconate: 0.590 mg
• Cobalt Gluconate: 0.553 mg
• Excipients: Purified water, Anhydrous glucose

📋 Recommended Dosage:

• Route: Oral, sublingual (under the tongue)
• Dosage: 1 to 2 ampoules per day
• Administration:
  • Hold the contents under your tongue for 1 to 2 minutes before swallowing.
  • Take preferably in the morning on an empty stomach, 15 minutes before a meal, or in the evening before bedtime.

⚠️ Precautions:

• Allergies: Do not use if allergic to any of the ingredients.
• Medical Conditions: Not suitable for individuals with glucose-galactose malabsorption syndrome.
• Pregnancy & Breastfeeding: Use is not recommended without medical advice.

📦 Packaging:

• Box of 28 ampoules (2 ml each)

🔄 Oligotherapy Support: Oligosol Manganese Cobalt ampoules offer gentle yet effective support for individuals experiencing neurovegetative imbalances.

For any concerns or specific advice, consult your healthcare professional.

Please read the following full disclosure before purchasing or using this item.

SUMMARY OF PRODUCT CHARACTERISTICS

ANSM - Updated on: 01/08/2023

1. NAME OF THE MEDICINAL PRODUCT

MANGANESE-COBALT OLIGOSOL, oral solution in ampoule

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

• Manganese Gluconate: 0.590 mg
  • (Corresponding amount of manganese: 0.0728 mg)
• Cobalt Gluconate: 0.553 mg
  • (Corresponding amount of cobalt: 0.0726 mg)
• Per 2 ml ampoule

Notable excipient: Glucose.

For the full list of excipients, see section 6.1.

3. PHARMACEUTICAL FORM

Oral solution in ampoule.

4. CLINICAL PARTICULARS

4.1 Therapeutic indications
Used as a terrain modifier, particularly in states of neurovegetative dystonia.

4.2 Posology and method of administration
Posology:

• Route of administration: Oral.
• Sublingual administration is recommended.
• Adults only.

Dosage:

• 1 to 2 ampoules per day.

Administration instructions:

• Preferably taken in the morning on an empty stomach.
• Alternatively, 15 minutes before a meal or at bedtime.
• Hold the contents of the ampoule under the tongue for 1 to 2 minutes before swallowing.

Method of administration: Oral route.

4.3 Contraindications

• Hypersensitivity to the active substances or any of the excipients listed in section 6.1.

4.4 Special warnings and precautions for use

• This medicine contains glucose.
• Not recommended for patients with glucose-galactose malabsorption syndrome.

4.5 Interaction with other medicinal products and other forms of interaction

• No clinically significant interactions have been reported to date.

4.6 Fertility, pregnancy, and lactation

• In the absence of experimental and clinical data, the use of this medicine is not recommended during pregnancy and breastfeeding.

4.7 Effects on the ability to drive and use machines

• Not applicable.

4.8 Undesirable effects

• Reporting of suspected adverse reactions:
  Reporting suspected adverse reactions after authorization is important. It allows continuous monitoring of the benefit-risk balance of the medicine.
  Healthcare professionals are encouraged to report any suspected adverse reactions via the national reporting system:
  National Agency for the Safety of Medicines and Health Products (ANSM) and Regional Pharmacovigilance Centers Network – Website: www.signalement-sante.gouv.fr

4.9 Overdose

• No cases of overdose have been reported.

5. PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

• Pharmacotherapeutic class: OLIGOTHERAPY (V: Various)
• Trace minerals.

5.2 Pharmacokinetic properties

• Not provided.

5.3 Preclinical safety data

• Not provided.

6. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

• Anhydrous glucose
• Purified water

6.2 Incompatibilities

• Not applicable.

6.3 Shelf life

• 5 years

6.4 Special precautions for storage

• Store at a temperature below 25°C.

6.5 Nature and contents of container

• 2 ml ampoule with two breakable tips made of colorless glass (Type I)
• Box of 14 or 28 ampoules

6.6 Special precautions for disposal and handling

• No special requirements.

7. MARKETING AUTHORISATION HOLDER

LABCATAL
1198 Avenue du Docteur Maurice Donat
ZAC du Font de l’Orme
06250 Mougins, France

8. MARKETING AUTHORISATION NUMBERS

• 34009 329 575 7 6: 2 ml ampoule (colorless glass), box of 14.
• 34009 375 473 9 0: 2 ml ampoule (colorless glass), box of 28.

9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

[To be completed by the Marketing Authorization Holder]

10. DATE OF REVISION OF THE TEXT

[To be completed by the Marketing Authorization Holder]

11. DOSIMETRY

• Not applicable.

12. INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS

• Not applicable.

PRESCRIPTION AND DISPENSING CONDITIONS:

• This medicine is not subject to medical prescription.

If you have any concerns or require further clarification, please consult your healthcare professional.